Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer

British Journal of Cancer

Volumn 75, Issue 4, 1997, Pages 579-588

  Zarghami, N ^a,b   Grass, L ^a   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Androgens; Anti cancer agents; Antiandrogens; Antiprogestins; Breast cancer; Progestins; Prostate specific antigen; PSA gene regulation; Steroid hormone receptors

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYPROTERONE ACETATE; GESTAGEN; GLUCOCORTICOID; MESSENGER RNA; MIFEPRISTONE; MINERALOCORTICOID; NORGESTIMATE; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; STEROID HORMONE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; PRIORITY JOURNAL;

EID: 0031045630     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.101     Document Type: Article

References (43)

1. Bergqvist A, Bergqvist D and Ferno M (1993) Estrogen and progesterone receptors in vessel walls: biochemical and immunological assays. Acta Obstet Gynecol Scand 72: 10-16
2. Berthois Y, Katzenellenbogen JA and Katzenellenbogen BS (1986) Phenol red in tissue culture medium is a weak estrogen: implications concerning the study of estrogen responsive cells in culture. Proc Natl Acad Sci USA 83: 2496-2500
3. Boivin G, Terrier-Anthoine C and Morel G (1994) Ultrastructural localization of endogenous hormones and receptors in bone tissue: an immunocytological approach in frozen samples. Micron 25: 15-27
4. Carroll RS, Glowacka D, Dashner K and Black PM (1993) Progesterone receptors in meningiomas. Cancer Res 53: 1312-1316
5. Clements A and Mukhtar A (1994) Glandular kallikriens and prostate specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 78: 1536-1539
6. Deguchi T, Dio T, Ehara H, ITO S, Takahashi Y, Nishino Y, Fujihiro S, Kawamura T, Komeda H, Horie M, Kaji H, Shimokawa K, Tanaka T and Kawada Y (1993) Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 53: 5350-5354
7. Diamandis EP and Yu H (1995) New biological functions of prostate specific antigen? J Clin Endocrinol Metab 80: 1515-1517
8. Digby M, Zhang XY and Richards RI (1989) Human prostate specific antigen (PSA) gene: structure and linkage to the kallikrein-like gene. hGK-1. Nucleic Acids Res 17: 2137
9. Ferguson RA, Yu H, Kalyvas M, Zummit S and Diamandis EP (1996) Ultrasensitive detection of prostate specific antigen by a new time resolved immunofluorometric assay and the Immulite immunochemiluminescent third generation assay: potential applications in prostate and breast cancers. Clin Chem. 42: 675-684
10. Glover JF and Darbre FD (1989) Multihormone regulation of MMTV-LTR in transfected T-47D human breast cancers. J Steroid Biochem 32: 357-363
11. Gravanis A, Schaison G, George M, Debrux J, Satyaswaroop PG, Baulieu EE and Robel P (1985) Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women. J Clin Endocrinol Metab. 60: 156-163
12. Gronemeyer H, Meyer M-E, Bocquel M-T, Kastner P, Turcotte B and Chambon P (1991) Progestin receptors: isoforms and antihormone action. J Steroid Biochem Mol Biol 40: 271-278
13. Henttu P and Vihko P (1989) cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes. Biochem Biophys Res Commun 160: 903-910
14. Henttu P, Liao S and Vihko P (1992) Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130: 766-772
15. Kafrissen ME (1992) A norgestimate-containing oral contraceptive: review of clinical studies. Am J Obstet Gynecol 167: 1196-1202
16. Klobeck HG, Combriato G, Schulz P, Arbuson V and Fittler F (1989) Genomic sequence of human prostate specific antigen (PSA). Nucleic Acids Res 17: 3981
17. Lea OA, Kuinnsland S and Thorsen T (1989) Improved measurement of androgen receptors in human breast cancer. Cancer Res 49: 7162-7167
18. Levine AC (1995) Pathogenesis and medical management of benign prostatic hyperplasia. Trends Endocrinol Metab 6: 128-132
19. Luke MC and Coffey DS (1994) Human androgen receptor binding to the androgen response element of prostate specific antigen. J Androl 15: 41-51
20. Lundwall A (1989) Characterization of the gene for prostate specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun 161: 1151-1159
21. Lundwall A and Lilja H (1987) Molecular cloning of human prostate specific antigen cDNA. Febs Lett. 214: 317-322
22. Mobbs BG and Liu Y (1990) Immunohistochemical localization of progesterone receptor in benign and malignant human prostate. Prostate 16: 245-251
23. Murtha P, Tindall DJ and Young CYF (1993) Androgen induction of a human prostate specific kallidrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry 32: 6459-6464
24. Nordeen SK, Kuhnel B, Lawler-Heavner J, Barber DA and Edwards DP (1989) A quantitative comparison of dual control of hormone response element by progestins and glucocorticoids in the same cell line. Mol Endocrinol 3: 1270-1278
25. Ojasso T, Dore JC, Gilbert J and Raynaud JP (1988) Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis. J Med Chem 31: 1160-1169
26. Okazaki T (1992) Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay: comparison with dextran coated charcol (DCC) assay and immunocytochemical assay. Jpn J Cancer Chemother 19: 361-366
27. Pacchioni D, Revelli A, Casetta G, Cassoni P, Piana P, Tizzani A, Buscati G and Massobrio M (1992) Immunochemical detection of estrogen and progesterone receptors in the normal urinary bladder and in pseudomembranous trigonitis. J Endocrinol Invest 15: 719-725
28. Pearce D and Yamamoto KR (1993) Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at composite response element. Science 259: 1161-1165
29. Philibert D, Moguilewsky M, Mary I, Lecaque D, Tournemine C, Secchi J and Deraedt R (1985) Pharmacological profile of RU 486 in animals. In The Antiprogestin Steroid RU 486 and Human Fertility Control, Beaulieu EE and Segal SJ (eds), pp. 49-68. Plenum Publishing: New York
30. Phillips A (1990) The selectivity of a new progestin. Acta Obstet Gynecol Scand 152 (Suppl): 21-24
31. Phillips A, Hahn DW and McGuire JL (1992) Preclinical evaluation of norgestimate. a progestin with minimal androgenic activity. Am J Obstet Gynecol 167: 1191-1196
32. Riegman PH, Klaassen P, Van Der Korput JA, Romijn JC and Trapman J (1998) Molecular cloning and characterization of novel prostate antigen cDNA's. Biochem Biophys Res Commun 155: 181-188
33. Riegman PH, Vliestra RJ, Van Der Korput Jagm, Brinkman AO and Trapman J (1991) The promoter of the prostate specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 5: 1921-1930
34. Schulz P, Stucka R, Feldmann H, Combriato G, Klobeck HG, and Fittler. F (1988) Sequence of a cDNA clone encompassing the complete mature human prostate specific antigen (PSA) and an unspliced leader sequence. Nucleic Acids Res 16: 6226
35. Smith MR, Biggar S and Hussain M (1995) Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 55: 2640-2644
36. Teutsch G, Goubet F, Battmann T, Bonfils A, Bouchoux F, Cerede E, Gofflo D, Gaillard-Kelly M and Philibert D (1994) Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor. J Steroid Biochem Mol Biol 48: 111-119
37. Wehle H, Moll J and Cato ACB (1995) Molecular identification of steroid analogs with dissociated antiprogestin activities. Steroids 60: 368-374
38. Yu H, Diamandis EP and Sutherland DJA (1994a) Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 27: 75-79
39. Yu H, Diamandis EP, Zarghami N and Grass L (1994b) Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 32: 291 300
40. Yu H, Diamandis EP, Monne M and Croce CM (1995a) Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 270: 6615-6618
41. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, Roagna R, Ponzone R and Sismondi P (1995b) Prostate specific antigen is a new favourable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110
42. Yu H, Diamandis EP, Levesque M, ASA S, Monne M and Croce CM (1995c) Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Res 55: 1603-1606
43. 3H]methyltrienolone (R1881) in the presence of progesterone receptors. Endocrinology 104: 1007-1012